COVID-19: a potential driver of immune-mediated breast cancer recurrence?

Severe coronavirus disease 2019 (COVID-19) causes a hyperactivation of immune cells, resulting in lung inflammation. Recent studies showed that COVID-19 induces the production of factors previously implicated in the reawakening of dormant breast cancer cells such as neutrophil extracellular traps (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Francescangeli, Federica, De Angelis, Maria Laura, Zeuner, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598231/
https://www.ncbi.nlm.nih.gov/pubmed/33126915
http://dx.doi.org/10.1186/s13058-020-01360-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598231/
https://www.ncbi.nlm.nih.gov/pubmed/33126915
http://dx.doi.org/10.1186/s13058-020-01360-0

Ejemplares similares